Relief of Lower Urinary Tract Symptoms after MRI-Guided Transurethral Ultrasound Ablation (TULSA) for localized prostate cancer: Subgroup Analyses in Patients with concurrent cancer and Benign Prostatic Hyperplasia

2020 ◽  
Author(s):  
Dean Elterman ◽  
William Li ◽  
Gencay Hatiboglu ◽  
James Relle ◽  
Kevin C. Zorn ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Lower Urinary Tract ◽  
Prostatic Hyperplasia ◽  
Urinary Tract Symptoms ◽  
Subgroup Analyses ◽  
Ultrasound Ablation ◽  
Mri Guided ◽  
Transurethral Ultrasound ◽  
Concurrent Cancer ◽  
Lower Urinary

scholarly journals Biomarkers in the setting of benign prostatic hyperplasia-induced lower urinary tract symptoms: what an interventional radiologist needs to know

2020 ◽  
Vol 93 (1114) ◽  
pp. 20200484
Author(s):  
Shamar Young ◽  
Alessandro Gasparetto ◽  
Hamed Jalaeian ◽  
Jafar Golzarian
Keyword(s):  
Prostate Cancer ◽  
Urinary Tract ◽  
Benign Prostatic Hyperplasia ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Specific Antigen ◽  
Prostate Cancer Risk ◽  
Prostatic Hyperplasia ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

With increasing evidence to support prostate artery embolization (PAE) in the treatment of benign prostatic hyperplasia (BPH)-induced lower urinary tract symptoms (LUTS), Interventional Radiologists have begun to play an important role in the management of these patients. One area of knowledge needed when developing a PAE practice is knowledge of prostate-specific antigen (PSA) and other biomarkers utilized to detect prostate cancer in this population and what role they should play in the work up and follow-up of patients presenting with presumed BPH-induced LUTS. Furthermore, understanding how to evaluate presumed BPH-induced LUTS and stratify the risk of prostate cancer is an important skill to develop. The goal of this review is to provide Interventional Radiologists who have begun or aim to begin a PAE practice with the information they need to know regarding PSA levels and prostate cancer risk stratification for this patient population.

1328: A Proteomic Urine Protein Study in Men with Benign Prostatic Hyperplasia or Prostate Cancer and Lower Urinary Tract Symptoms

2004 ◽  
Vol 171 (4S) ◽  
pp. 350-350
Author(s):  
Robert A. Henningsen ◽  
Stewart W. McCallum ◽  
Wanda Kwan ◽  
Brenda L. Schwartz ◽  
Kenneth M. Straub ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Urinary Tract ◽  
Benign Prostatic Hyperplasia ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Prostatic Hyperplasia ◽  
Urine Protein ◽  
Urinary Tract Symptoms ◽  
Lower Urinary
Sign in / Sign up

Export Citation Format

Share Document